Page last updated: 2024-10-27

fluorouracil and Gangrene

fluorouracil has been researched along with Gangrene in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Gangrene: Death and putrefaction of tissue usually due to a loss of blood supply.

Research Excerpts

ExcerptRelevanceReference
"Celecoxib dosage was fixed."2.75A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer. ( Alqaisi, M; Bernal, P; Bush, D; Byrd, J; Garberoglio, C; Hussein, F; Malik, I, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malik, I1
Hussein, F1
Bush, D1
Alqaisi, M1
Bernal, P1
Byrd, J1
Garberoglio, C1
Zilling, TL1
Ahrén, B1

Trials

1 trial available for fluorouracil and Gangrene

ArticleYear
A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.
    American journal of clinical oncology, 2010, Volume: 33, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitab

2010

Other Studies

1 other study available for fluorouracil and Gangrene

ArticleYear
Ischaemic pancolitis: a serious complication of chemotherapy in a previously irradiated patient. Case report.
    Acta chirurgica Scandinavica, 1989, Volume: 155, Issue:1

    Topics: Carcinoma, Squamous Cell; Cisplatin; Colitis; Combined Modality Therapy; Dysgerminoma; Esophageal Ne

1989